Intrinsiqq
Accustem Sciences Inc. logo

Accustem Sciences Inc.

ACUT

Compare
⚠ Showing the latest available close (Nov 19, 2026, 3 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$2M
EPS-$0.22
P/E-0.54
P/FCF-2.25
EV/EBITDA-0.62
FCF Yield–
Div. Yield–
Net Debt/FCF-0.0x
Accustem Sciences Inc. intrinsic value
52-Week Range
$0.12$0.35

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$3M

▼ -16.7% YoY

Op. Margin

–

ROIC

-7751.96%

▼ -2875.4pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$842K

▼ -28.1% YoY

Op. Cash Flow (TTM)

-$842K

▼ -28.1% YoY

Net Debt

$27K

Cash & Equiv.

$15K

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with ACUT

CompareIntrinsic value
OWPCOne World Products Inc.
$0.00+0.00%46
GCANThe Greater Cannabis Company, Inc.
$0.75-24.09%20
EMMAEmmaus Life Sciences, Inc.
$0.04+52.17%21
CPHIChina Pharma Holdings Inc.
$0.44-12.32%25
ENTAEnanta Pharmaceuticals Inc.
$7.62-4.51%25
BDPTBioadaptives Inc.
$0.00-4.00%25
SKVISkinvisible Inc.
$0.18+0.00%0
PMHSPolomar Health Services Inc.
$0.15+45.00%30

Accustem Sciences (ACUT) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-0.54
Negative: a loss over the last twelve months. Price to free cash flow -2.25.
Financials

Questions about Accustem Sciences

Does Accustem Sciences (ACUT) pay a dividend?

No. Accustem Sciences (ACUT) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 20 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 19 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in ACUT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ACUT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.